parinaric acid has been researched along with dinoprost in 2 studies
| Studies (parinaric acid) | Trials (parinaric acid) | Recent Studies (post-2010) (parinaric acid) | Studies (dinoprost) | Trials (dinoprost) | Recent Studies (post-2010) (dinoprost) |
|---|---|---|---|---|---|
| 223 | 0 | 11 | 11,554 | 940 | 1,936 |
| Protein | Taxonomy | parinaric acid (IC50) | dinoprost (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.0025 | |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 0.0713 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.14 | |
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.3 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.14 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 4.2 | |
| Prostaglandin F2-alpha receptor | Bos taurus (cattle) | 0.14 | |
| Prostaglandin F2-alpha receptor | Homo sapiens (human) | 0.0139 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.216 | |
| Prostaglandin D2 receptor | Homo sapiens (human) | 4.5 | |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.287 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornelius, AS; Ryken, TC; Traynelis, VC | 1 |
| Bar-Sagi, D; Defilippi, SJ; Epperly, MW; Greenberger, JS; Gretton, JE; Kagan, VE; Sikora, CA | 1 |
2 other study(ies) available for parinaric acid and dinoprost
| Article | Year |
|---|---|
Cytotoxicity of cis-parinaric acid in cultured malignant gliomas.
Topics: Animals; Antineoplastic Agents; Arachidonic Acids; Astrocytes; Brain Neoplasms; Cell Line; Cell Survival; Dinoprost; Dose-Response Relationship, Drug; F2-Isoprostanes; Fatty Acids, Unsaturated; Glioma; Humans; Lipid Peroxidation; Rats; Tumor Cells, Cultured | 1995 |
Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated radiation.
Topics: Animals; Biomarkers; Cells, Cultured; Chromatography, High Pressure Liquid; Dinoprost; Dose-Response Relationship, Drug; Epitopes; Esophagitis; Fatty Acids, Unsaturated; Female; Hemagglutinins; Lac Operon; Lipid Metabolism; Lipid Peroxidation; Liposomes; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Plasmids; Radiotherapy; Superoxide Dismutase; Time Factors | 2001 |